Hydroxyzine Pamoate
Product Images NDC 67296-1719

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 67296-1719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ad1baa19 A28b 4299 Aa20 87b920fff33a 01)

Chemical structure diagram showing the active ingredient hydroxyzine pamoate. Two molecular structures are displayed side-by-side, representing hydroxyzine and the pamoate component.*

FDA Label Image

Image (Ad1baa19 A28b 4299 Aa20 87b920fff33a 02)

FDA Label Image

Label (Hydrox Pamoate 1719)

Two hydroxyzine pamoate capsule bottle labels from RedPharm Drug, Inc. showing 25mg strength. One label indicates 30 capsules, lot 190518X1, expiration 05/21. The other indicates 15 capsules, lot 190518X2, expiration 05/21. Both note Rx only, storage at controlled room temperature, manufacturer Heritage Pharma Labs Inc, East Brunswick NJ, and distributor Redpharm Drug, Eden Prairie, MN. Barcodes and lot information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.